![Michael M. Wick](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Career history of Michael M. Wick
Former positions of Michael M. Wick
Companies | Position | Start | End |
---|---|---|---|
MABVAX THERAPEUTICS HOLDINGS, INC. | Director/Board Member | 2014-07-07 | 2015-04-02 |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Chief Tech/Sci/R&D Officer | 1995-04-30 | 1997-11-30 |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Corporate Officer/Principal | 1990-08-31 | 1995-04-30 |
Harvard Medical School | Corporate Officer/Principal | 1981-05-31 | 1994-05-31 |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Corporate Officer/Principal | 1980-08-31 | - |
Telik, Inc.
![]() Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Director/Board Member | 2014-07-07 | - |
Chief Executive Officer | 1997-11-30 | 2014-07-07 | |
Chairman | 1997-11-30 | 2014-07-07 | |
President | 1997-11-30 | 2014-07-07 |
Training of Michael M. Wick
Harvard University | Doctorate Degree |
Harvard Medical School | Doctorate Degree |
Statistics
International
United States | 8 |
Operational
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Doctorate Degree | 2 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 5 |
---|---|
Telik, Inc.
![]() Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | Health Technology |
CV Therapeutics, Inc.
![]() CV Therapeutics, Inc. BiotechnologyHealth Technology CV Therapeutics™ is a biopharmaceutical company focused on the application of molecular cardiology to the discovery, development and commercialization of novel, small molecule drugs for the treatment of cardiovascular diseases | Health Technology |
Lederle Laboratories
![]() Lederle Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Pfizer Inc., Lederle Laboratories is a company that provides testing services. The company is based in Pearl River, NY. | Commercial Services |
MabVax Therapeutics Holdings, Inc.
![]() MabVax Therapeutics Holdings, Inc. Pharmaceuticals: MajorHealth Technology MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA. | Health Technology |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Health Services |
- Stock Market
- Insiders
- Michael M. Wick
- Experience